Colony Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,000
| Closed | -$46K | – | 809 |
|
|
2023
Q1 | $46K | Buy |
+25,000
| New | +$46K | ﹤0.01% | 774 |
|
|
2022
Q4 | – | Sell |
-20,000
| Closed | -$47K | – | 900 |
|
|
2022
Q3 | $47K | Hold |
20,000
| – | – | ﹤0.01% | 762 |
|
|
2022
Q2 | $61K | Hold |
20,000
| – | – | ﹤0.01% | 803 |
|
|
2022
Q1 | $136K | Hold |
20,000
| – | – | ﹤0.01% | 819 |
|
|
2021
Q4 | $167K | Buy |
20,000
+10,000
| +100% | +$83.5K | ﹤0.01% | 782 |
|
|
2021
Q3 | $74K | Hold |
10,000
| – | – | ﹤0.01% | 814 |
|
|
2021
Q2 | $255K | Hold |
10,000
| – | – | 0.01% | 686 |
|
|
2021
Q1 | $103K | Hold |
10,000
| – | – | ﹤0.01% | 747 |
|
|
2020
Q4 | $70K | Hold |
10,000
| – | – | ﹤0.01% | 724 |
|
|
2020
Q3 | $82K | Buy |
+10,000
| New | +$82K | ﹤0.01% | 708 |
|